Evidence map›Paper›PMID 30637985›Full record

ArticleJournal of cachexia, sarcopenia and muscle2018

Cachexia as a common characteristic in multiple chronic disease.

Nadja Scherbakov, Wolfram Doehner

2 registry-linked trialsAbstract readEditorial
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05588375 naunknown statusnot on this mapstarted 2022, after this paper: background citation

The Effects of Home-based Physical Activity Telemonitoring Program in Patients With Heart Failure and Muscle Wasting in the Post-epidemic Era

TypeinterventionalSponsorFar Eastern Memorial HospitalRan2022 to 2023Enrolled118ConditionsSarcopenia, Muscular Atrophy, Wasting Syndrome, Heart FailureArmshome-based physical activity telemonitoring program
NCT07231120 phase1recruitingnot on this mapstarted 2025, after this paper: background citation

A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia

TypeinterventionalSponsorJiangsu Nutai Biologics Co., LtdRan2025 to 2026Enrolled54ConditionsCachexia-Anorexia Syndrome, Solid Tumor MalignanciesArmsSXRN Injection
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Multimodal interventions for cachexia management.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. A Critical Review of Multimodal Interventions for Cachexia.Advances in nutrition (Bethesda, Md.) · 2021
    Review
  8. Weight loss, malnutrition, and cachexia in COVID-19: facts and numbers.Journal of cachexia, sarcopenia and muscle · 2021
    Article
  9. Article
  10. Article
  11. Review
  12. Muscle Wasting and Sarcopenia in Heart Failure-The Current State of Science.International journal of molecular sciences · 2020
    Review
  13. Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery.International journal of molecular sciences · 2020
    Review
  14. Review
  15. Review
  16. Review
  17. Heart failure management of the elderly patient: focus on frailty, sarcopaenia, cachexia, and dementia: conclusions.European heart journal supplements : journal of the European Society of Cardiology · 2019
    Article
  18. Care plans for the older heart failure patient.European heart journal supplements : journal of the European Society of Cardiology · 2019
    Article
  19. Cardiac cachexia.European heart journal supplements : journal of the European Society of Cardiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nadja ScherbakovDepartment of Cardiology (CVK), Charité-Universitätsmedizin Berlin, Berlin, Germany.
Wolfram DoehnerDepartment of Cardiology (CVK), Charité-Universitätsmedizin Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CachexiaHumansMultiple Chronic Conditionscachexiacancerchronic diseasesmuscle wasting

Identifiers

PMID30637985
PMCPMC6351667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.